1. Home
  2. XRAY vs APLS Comparison

XRAY vs APLS Comparison

Compare XRAY & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

N/A

Current Price

$12.80

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

N/A

Current Price

$20.17

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XRAY
APLS
Founded
1899
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
XRAY
APLS
Price
$12.80
$20.17
Analyst Decision
Hold
Buy
Analyst Count
13
20
Target Price
$15.00
$31.89
AVG Volume (30 Days)
5.4M
1.8M
Earning Date
05-21-2026
04-02-2026
Dividend Yield
5.02%
N/A
EPS Growth
33.04
112.50
EPS
N/A
0.20
Revenue
N/A
$1,003,782,000.00
Revenue This Year
$1.63
N/A
Revenue Next Year
$2.49
$17.97
P/E Ratio
N/A
$100.80
Revenue Growth
N/A
28.46
52 Week Low
$9.85
$16.10
52 Week High
$17.18
$30.48

Technical Indicators

Market Signals
Indicator
XRAY
APLS
Relative Strength Index (RSI) 48.31 36.66
Support Level $12.06 $18.95
Resistance Level $13.08 $20.42
Average True Range (ATR) 0.71 0.98
MACD -0.06 -0.16
Stochastic Oscillator 25.24 24.14

Price Performance

Historical Comparison
XRAY
APLS

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: